US EditionPublished • loading... • Updated
Eli Lilly to invest $5 billion in new Virginia plant as pharma braces for tariffs
The $5 billion facility will create over 650 high-wage jobs and focus on antibody-drug conjugates to enhance domestic production and strengthen the pharmaceutical supply chain.
- Eli Lilly said it will spend $5 billion to build a manufacturing facility in Goochland County, Virginia, to boost production capacity for targeted cancer drugs and other treatments.
- Drugmakers have been scrambling to boost their production in the U.S. as President Donald Trump threatens to clamp down on the industry with tariffs on pharmaceuticals imported into the country.
- The new U.S. investments build on the success of Eli Lilly's weight loss drug Zepbound and diabetes counterpart Mounjaro, which have vied for dominance of the booming market for so-called GLP-1 drugs with rival treatments from Novo Nordisk.
Insights by Ground AI
15 Articles
15 Articles
InsideNoVA.comReposted by 
Virginia Mercury
Virginia MercuryDrug manufacturer Eli Lilly to build plant in Goochland, create 650 permanent jobs
Amtrak trains arrived and departed Tuesday morning at Richmond’s Main Street Station as state and local lawmakers announced pharmaceutical company Eli Lilly will construct a $5 billion manufacturing facility in Virginia that is slated to bring hundreds of jobs to…
Coverage Details
Total News Sources15
Leaning Left4Leaning Right2Center9Last UpdatedBias Distribution60% Center
Bias Distribution
- 60% of the sources are Center
60% Center
L 27%
C 60%
13%
Factuality
To view factuality data please Upgrade to Premium
